Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Tibolla, Gianpaolo ^a,b,c   Piñeiro, Roberto ^a   Chiozzotto, Daniela ^a   Mavrommati, Ioanna ^a   Wheeler, Ann P ^a   Norata, Giuseppe Danilo ^a,b,c   Catapano, Alberico Luigi ^b,d   Maffucci, Tania ^a   Falasca, Marco ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

^c Bassini Hospital   (Italy)

^d IRCCS MULTIMEDICA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HOSPHATIDYLINOSITOL 3 KINASE C2ALPHA; HOSPHATIDYLINOSITOL 3 KINASE C2BETA; MATRIGEL; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN P110 GAMMA; SPHINGOLIPID SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; MORPHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; ISOENZYMES; LYSOPHOSPHOLIPIDS; MORPHOGENESIS; PHOSPHATIDYLINOSITOL 3-KINASES; SPHINGOSINE;

EID: 84872186366     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053808     Document Type: Article

References (42)

1. Falasca M, Maffucci T, (2012) Regulation and cellular functions of class II phosphoinositide 3-kinases. Biochem J 443: 587-601.
2. Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B, (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 11: 329-341.
3. Falasca M, Maffucci T, (2009) Rethinking phosphatidylinositol 3-monophosphate. Biochim Biophys Acta 1793: 1795-1803.
4. Falasca M, Hughes WE, Dominguez V, Sala G, Fostira F, et al. (2007) The role of phosphoinositide 3-kinase C2alpha in insulin signaling. J Biol Chem 282: 28226-28236.
5. Maffucci T, Cooke FT, Foster FM, Traer CJ, Fry MJ, et al. (2005) Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration. J Cell Biol 169: 789-799.
6. Falasca M, Maffucci T, (2007) Role of class II phosphoinositide 3-kinase in cell signalling. Biochem Soc Trans 35: 211-214.
7. Yoshioka K, Yoshida K, Cui H, Wakayama T, Takuwa N, et al. (2012) Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function. Nat Med 18: 1560-1569.
8. Arcaro A, Khanzada UK, Vanhaesebroeck B, Tetley TD, Waterfield MD, et al. (2002) Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation. EMBO J 21: 5097-5108.
9. Mazza S, Maffucci T, (2011) Class II Phosphoinositide 3-kinase C2alpha: what we learned so far. Int J Biochem. Mol Biol 2: 168-182.
10. Maceyka M, Milstien S, Spiegel S, (2009) Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling. J Lipid Res 50Suppl:S272-S276.
11. Spiegel S, Milstien S, (2003) Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4: 397-407.
12. Yatomi Y, (2008) Plasma sphingosine 1-phosphate metabolism and analysis. Biochim Biophys Acta 1780: 606-611.
13. Zhang B, Tomura H, Kuwabara A, Kimura T, Miura S, et al. (2005) Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins. Atherosclerosis 178: 199-205.
14. Kontush A, Therond P, Zerrad A, Couturier M, Négre-Salvayre A, et al. (2007) Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities. Arterioscler Thromb Vasc Biol 27: 1843-1849.
15. Hla T, (2004) Physiological and pathological actions of sphingosine 1-phosphate. Sem Cell Develop Biol 15: 513-520.
16. Lucke S, Levkau B, (2010) Endothelial functions of sphingosine-1-phosphate. Cell Physiol Biochem 26: 87-96.
17. Yang AH, Ishii I, Chun J, (2002) In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice. Biochim Biophys Acta 1582: 197-203.
18. Allende ML, Yamashita T, Proia RL, (2003) G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood 102: 3665-3667.
19. Rivera R, Chun J, (2008) Biological effects of lysophospholipids. Rev Physiol Biochem Pharmacol 160: 25-46.
20. Argraves KM, Argraves WS, (2007) HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects. J Lipid Res 48: 2325-2333.
21. Lee OH, Kim YM, Lee YM, Moon EJ, Lee DJ, et al. (1999) Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem Biophys Res Commun 264: 743-750.
22. Heller R, Chang Q, Ehrlich G, Hsieh SN, Schoenwaelder SM, et al. (2008) Overlapping and distinct roles for PI3Kbeta and gamma isoforms in S1P-induced migration of human and mouse endothelial cells. Cardiovascular Res 80: 96-105.
23. Domin J, Pages F, Volinia S, Rittenhouse SE, Zvelebil MJ, et al. (1997) Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin. Biochem J 326: 139-147.
24. Norata GD, Tibolla G, Seccomandi PM, Poletti A, Catapano AL, (2006) Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells. J Clin Endocrinol Metab 91: 546-554.
25. Maffucci T, Piccolo E, Cumashi A, Iezzi M, Riley AM, et al. (2005) Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects. Cancer Res 65: 8339-8349.
26. Jamieson S, Flanagan JU, Kolekar S, Buchanan C, Kendall JD, et al. (2011) A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types. Biochem J. 438: 53-62.
27. Elis W, Triantafellow E, Wolters NM, Sian KR, Caponigro G, et al. (2008) Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death. Mol Cancer Res 6: 614-623.
28. Katso RM, Pardo OE, Palamidessi A, Franz CM, Marinov M, et al. (2006) Phosphoinositide 3-Kinase C2beta regulates cytoskeletal organization and cell migration via Rac-dependent mechanisms. Mol Biol Cell. 17: 3729-3744.
29. Morello F, Perino A, Hirsch E, (2009) Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc Res 82: 261-271.
30. Graupera M, Guillermet-Guibert J, Foukas LC, Phng LK, Cain RJ, et al. (2008) Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration. Nature 453: 662-666.
31. Madeddu P, Kraenkel N, Barcelos LS, Siragusa M, Campagnolo P, et al. (2008) Phosphoinositide 3-kinase gamma gene knockout impairs postischemic neovascularization and endothelial progenitor cell functions. Arterioscler Thromb Vasc Biol 28: 68-76.
32. Harada K, Truong AB, Cai T, Khavari PA, (2005) The class II phosphoinositide 3-kinase C2beta is not essential for epidermal differentiation. Mol Cell Biol 25: 11122-11130.
33. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, et al. (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256: 2835-2838.
34. Kwiterovich PO Jr, (1998) The antiatherogenic role of high-density lipoprotein cholesterol. Am J Cardiol 82: 13Q-21Q.
35. Calabresi L, Gomaraschi M, Franceschini G, (2003) Endothelial protection by high-density lipoproteins: from bench to bedside. Arterioscler Thromb Vasc Biol 23: 1724-1731.
36. Norata GD, Callegari E, Inoue H, Catapano AL, (2004) HDL3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: effects on COX-2/PGI-synthase coupling. Arterioscler Thromb Vasc Biol 24: 871-877.
37. Mineo C, Yuhanna IS, Quon MJ, Shaul PW, (2003) High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem 278: 9142-9149.
38. Murugesan G, Sa G, Fox PL, (1994) High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor. Circ Res 74: 1149-1156.
39. Seetharam D, Mineo C, Gormley AK, Gibson LL, Vongpatanasin W, et al. (2006) High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res. 98: 63-72.
40. Kimura T, Sato K, Malchinkhuu E, Tomura H, Tamama K, et al. (2003) High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. Arterioscler Thromb Vasc Biol 23: 1283-1288.
41. Matsuo Y, Miura S, Kawamura A, Uehara Y, Rye KA, et al. (2007) Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation. Atherosclerosis 194: 159-168.
42. Nofer JR, Assmann G, (2005) Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids. Trends Cardiovasc Med 15: 265-271.